Roche plans to di­vest from lega­cy Genen­tech man­u­fac­tur­ing fa­cil­i­ty in Cal­i­for­nia

Roche is plan­ning to make some changes to its sub­sidiary’s man­u­fac­tur­ing net­work in Cal­i­for­nia.

The Swiss phar­ma an­nounced Wednes­day that it plans to di­vest from Genen­tech’s man­u­fac­tur­ing fa­cil­i­ty in Va­cav­ille, CA, around 58 miles north­east of San Fran­cis­co. Ac­cord­ing to a state­ment from Roche, the move is part of a “broad­er strat­e­gy” to bring its man­u­fac­tur­ing ca­pa­bil­i­ties in line with its fu­ture pipeline. Roche is start­ing the process of find­ing a buy­er for the site but has not named any can­di­dates yet.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.